420 related articles for article (PubMed ID: 27845874)
1. Initial Single-Center Experience With the Fully Repositionable Transfemoral Lotus Aortic Valve System.
Jarr KU; Leuschner F; Meder B; Katus HA; Bekeredjian R; Chorianopoulos E
J Invasive Cardiol; 2017 Jan; 29(1):30-35. PubMed ID: 27845874
[TBL] [Abstract][Full Text] [Related]
2. Outcome With the Repositionable and Retrievable Boston Scientific Lotus Valve Compared With the Balloon-Expandable Edwards Sapien 3 Valve in Patients Undergoing Transfemoral Aortic Valve Replacement.
Seeger J; Gonska B; Rottbauer W; Wöhrle J
Circ Cardiovasc Interv; 2017 Jun; 10(6):. PubMed ID: 28566290
[TBL] [Abstract][Full Text] [Related]
3. New generation devices for transfemoral transcatheter aortic valve replacement are superior compared with last generation devices with respect to VARC-2 outcome.
Seeger J; Gonska B; Rottbauer W; Wöhrle J
Cardiovasc Interv Ther; 2018 Jul; 33(3):247-255. PubMed ID: 28643214
[TBL] [Abstract][Full Text] [Related]
4. Procedural and 30-day clinical outcomes following transcatheter aortic valve replacement with lotus valve: Results of the RELEVANT study.
Montone RA; Testa L; Fraccaro C; Montorfano M; Castriota F; Nerla R; Angelillis M; Tusa M; Giannini F; Garatti A; Tarantini G; Petronio AS; Brambilla N; Bedogni F
Catheter Cardiovasc Interv; 2017 Dec; 90(7):1206-1211. PubMed ID: 28145039
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of Redo Transcatheter Aortic Valve Replacement for the Treatment of Postprocedural and Late Occurrence of Paravalvular Regurgitation and Transcatheter Valve Failure.
Barbanti M; Webb JG; Tamburino C; Van Mieghem NM; Makkar RR; Piazza N; Latib A; Sinning JM; Won-Keun K; Bleiziffer S; Bedogni F; Kapadia S; Tchetche D; Rodés-Cabau J; Fiorina C; Nombela-Franco L; De Marco F; de Jaegere PP; Chakravarty T; Vaquerizo B; Colombo A; Svensson L; Lange R; Nickenig G; Möllmann H; Walther T; Della Rosa F; Elhmidi Y; Dvir D; Brambilla N; Immè S; Sgroi C; Gulino S; Todaro D; Pilato G; Petronio AS; Tamburino C
Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27578840
[TBL] [Abstract][Full Text] [Related]
6. Transfemoral aortic valve implantation with the repositionable Lotus valve compared with the balloon-expandable Edwards Sapien 3 valve.
Wöhrle J; Gonska B; Rodewald C; Trepte U; Koch S; Scharnbeck D; Seeger J; Markovic S; Rottbauer W
Int J Cardiol; 2015 Sep; 195():171-5. PubMed ID: 26043152
[TBL] [Abstract][Full Text] [Related]
7. Use of a Repositionable and Fully Retrievable Aortic Valve in Routine Clinical Practice: The RESPOND Study and RESPOND Extension Cohort.
Van Mieghem NM; Wöhrle J; Hildick-Smith D; Bleiziffer S; Blackman DJ; Abdel-Wahab M; Gerckens U; Linke A; Ince H; Wenaweser P; Allocco DJ; Meredith IT; Falk V
JACC Cardiovasc Interv; 2019 Jan; 12(1):38-49. PubMed ID: 30621976
[TBL] [Abstract][Full Text] [Related]
8. Transfemoral aortic valve implantation with new-generation devices: the repositionable Lotus vs. the balloon-expandable Edwards Sapien 3 valve.
Nai Fovino L; Badawy MRA; Fraccaro C; D'Onofrio A; Purita PAM; Frigo AC; Tellaroli P; Mauro A; Tusa M; Napodano M; Gerosa G; Iliceto S; Bedogni F; AbdelRheim AER; Tarantini G
J Cardiovasc Med (Hagerstown); 2018 Nov; 19(11):655-663. PubMed ID: 30299408
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the fully repositionable and retrievable Boston Lotus and direct flow medical valves for the treatment of severe aortic stenosis: A single center experience.
Giannini F; Latib A; Montorfano M; Ruparelia N; Romano V; Longoni M; Ferri L; Jabbour R; Mangieri A; Regazzoli D; Ancona M; Buzzatti N; Azzalini L; Tanaka A; Agricola E; Chieffo A; Alfieri O; Colombo A
Catheter Cardiovasc Interv; 2018 Apr; 91(5):966-974. PubMed ID: 28941127
[TBL] [Abstract][Full Text] [Related]
10. Prospective comparison between three TAVR devices: ACURATE neo vs. CoreValve vs. SAPIEN XT. A single heart team experience in patients with severe aortic stenosis.
Jatene T; Castro-Filho A; Meneguz-Moreno RA; Siqueira DA; Abizaid AAC; Ramos AIO; Arrais M; Le Bihan DCS; Barretto RBM; Moreira AC; Sousa AGMR; Eduardo Sousa J
Catheter Cardiovasc Interv; 2017 Jul; 90(1):139-146. PubMed ID: 28029207
[TBL] [Abstract][Full Text] [Related]
11. Transcatheter aortic valve replacement for severe symptomatic aortic stenosis using a repositionable valve system: 30-day primary endpoint results from the REPRISE II study.
Meredith Am IT; Walters DL; Dumonteil N; Worthley SG; Tchétché D; Manoharan G; Blackman DJ; Rioufol G; Hildick-Smith D; Whitbourn RJ; Lefèvre T; Lange R; Müller R; Redwood S; Allocco DJ; Dawkins KD
J Am Coll Cardiol; 2014 Sep; 64(13):1339-48. PubMed ID: 25257635
[TBL] [Abstract][Full Text] [Related]
12. The safety of introducing a new generation TAVR device: one departments experience from introducing a second generation repositionable TAVR.
Bjursten H; Nozohoor S; Johansson M; Zindovic I; Appel CF; Sjögren J; Dencker M; Olivecrona G; Harnek J; Koul S; Feldman T; Reardon MJ; Götberg M
BMC Cardiovasc Disord; 2017 Jan; 17(1):25. PubMed ID: 28086805
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of the Lotus Valve System for treatment of patients with severe aortic valve stenosis and intermediate surgical risk: Results from the Nordic Lotus-TAVR registry.
De Backer O; Götberg M; Ihlberg L; Packer E; Savontaus M; Nielsen NE; Jørgensen TH; Nykänen A; Baranowski J; Niemelä M; Eskola M; Bjursten H; Søndergaard L
Int J Cardiol; 2016 Sep; 219():92-7. PubMed ID: 27288972
[TBL] [Abstract][Full Text] [Related]
14. 1-Year Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients With Severe Aortic Stenosis: Results of the REPRISE II Study.
Meredith IT; Walters DL; Dumonteil N; Worthley SG; Tchétché D; Manoharan G; Blackman DJ; Rioufol G; Hildick-Smith D; Whitbourn RJ; Lefèvre T; Lange R; Müller R; Redwood S; Feldman TE; Allocco DJ; Dawkins KD
JACC Cardiovasc Interv; 2016 Feb; 9(4):376-384. PubMed ID: 26892084
[TBL] [Abstract][Full Text] [Related]
15. Initial Experience of a Second-Generation Self-Expanding Transcatheter Aortic Valve: The UK & Ireland Evolut R Implanters' Registry.
Kalra SS; Firoozi S; Yeh J; Blackman DJ; Rashid S; Davies S; Moat N; Dalby M; Kabir T; Khogali SS; Anderson RA; Groves PH; Mylotte D; Hildick-Smith D; Rampat R; Kovac J; Gunarathne A; Laborde JC; Brecker SJ
JACC Cardiovasc Interv; 2017 Feb; 10(3):276-282. PubMed ID: 28183467
[TBL] [Abstract][Full Text] [Related]
16. Early versus newer generation transcatheter heart valves for transcatheter aortic valve implantation: Echocardiographic and hemodynamic evaluation of an all-comers study cohort using the dimensionless aortic regurgitation index (AR-index).
Stundl A; Lucht H; Shamekhi J; Weber M; Sedaghat A; Mellert F; Grube E; Nickenig G; Werner N; Sinning JM
PLoS One; 2019; 14(5):e0217544. PubMed ID: 31150455
[TBL] [Abstract][Full Text] [Related]
17. Low permanent pacemaker rates following Lotus device implantation for transcatheter aortic valve replacement due to modified implantation protocol.
Krackhardt F; Kherad B; Krisper M; Pieske B; Laule M; Tschöpe C
Cardiol J; 2017; 24(3):250-258. PubMed ID: 28248410
[TBL] [Abstract][Full Text] [Related]
18. Transfemoral aortic valve implantation with the repositionable Lotus valve for treatment of patients with symptomatic severe aortic stenosis: results from a single-centre experience.
Wöhrle J; Gonska B; Rodewald C; Seeger J; Scharnbeck D; Rottbauer W
EuroIntervention; 2016 Aug; 12(6):760-7. PubMed ID: 27542789
[TBL] [Abstract][Full Text] [Related]
19. Procedural and thirty-day outcomes following transfemoral implantation of the fully repositionable and retrievable Lotus valve without routine pre-dilatation in a consecutive patient cohort: a single-center experience.
Ruparelia N; Thomas K; Newton JD; Grebenik K; Keiralla A; Krasopoulos G; Sayeed R; Banning AP; Kharbanda RK
Cardiovasc Revasc Med; 2018; 19(1 Pt B):78-82. PubMed ID: 29137967
[TBL] [Abstract][Full Text] [Related]
20. Repositionable Versus Balloon-Expandable Devices for Transcatheter Aortic Valve Implantation in Patients With Aortic Stenosis.
Pilgrim T; Stortecky S; Nietlispach F; Heg D; Tueller D; Toggweiler S; Ferrari E; Noble S; Maisano F; Jeger R; Roffi M; Grünenfelder J; Huber C; Wenaweser P; Windecker S
J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27856487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
